OR WAIT null SECS
October 14, 2024
Article
Anemia could be a reliable sign of all-cause mortality in patients with heart failure.
A systematic review found cognitive impairment a defining characteristic of SCA, with a notable impact on individuals of all ages.
October 11, 2024
The anti-TFPI significantly reduced ABR compared to routine prophylaxis treatment in the phase 3 BASIS trial.
October 08, 2024
Education and employment, social and emotional functioning, and healthcare access are notable factors influencing pain in sickle cell disease.
October 07, 2024
This retrospective analysis examined the current management of early and late anemia in a representative sample of the kidney transplant population in Spain.
Anemia is frequently observed in primary care patients with HF and is linked to worse prognosis and comorbidities, including cancer.
October 03, 2024
An elevated social vulnerability index score was linked to increased mortality among patients with SCD in the 5-year CDC WONDER database.
October 02, 2024
An analysis of NYC’s lead registry data from 2005 to 2019 revealed a potential association between sickle cell disease and childhood lead poisoning.
This month in review highlights vitamin D supplementation in anemia, the prevalence of iron deficiency in US adults, and the efficacy of rpFVIII in treating acquired hemophilia A.
October 01, 2024
Pfizer has announced the voluntary withdrawal of voxelotor in all markets after a report found the benefits do not outweigh the risks for sickle cell disease.